Trials
2 active
4 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Anemia (2 trials), Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia, Myelofibrosis; Anemia, Myelofibrosis, Myelofibrosis Due to and Following Polycythemia Vera, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis and 1 more
- Main trialPhase 2
- “This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.”In the company’s words, NCT07368972 on ClinicalTrials.gov
Other drugs for Anemia
- NTQ5082Nanjing Chia-tai Tianqing Pharmaceutical · Phase 3
- MY008211AWuhan Createrna Science and Technology Co., Ltd · Phase 3
- 20vPCVSanofi · Phase 3
- Pneumococcal Conjugate VaccineSanofi · Phase 3
- AND017Kind Pharmaceuticals LLC · Phase 3
- CrovalimabRoche · Phase 3
Coming up1
- May 2027Phase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Oct 2026 | Study of DISC-0974-201 in Participants With IBD and Anemia | |
| Phase 1/2Recruiting | May 2027 | Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia | |
| Phase 1Completed | 30 Jun 2022 | Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects | |
| Phase 1Completed | 9 Oct 2025 | Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026